167 related articles for article (PubMed ID: 35928866)
1. Image-guided interstitial brachytherapy for recurrent cervical cancer after radiotherapy: A single institution experience.
Ren X; Fu Y; Liu Z; Lin X; Qiu L; Li Y; Li H; Bai Y; Wang T
Front Oncol; 2022; 12():943703. PubMed ID: 35928866
[TBL] [Abstract][Full Text] [Related]
2. HDR brachytherapy for the reirradiation of cervical and vaginal cancer: analysis of efficacy and dosage delivered to organs at risk.
Zolciak-Siwinska A; Bijok M; Jonska-Gmyrek J; Kawczynska M; Kepka L; Bujko K; Michalski W
Gynecol Oncol; 2014 Jan; 132(1):93-7. PubMed ID: 24161366
[TBL] [Abstract][Full Text] [Related]
3. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
Lee LJ; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
[TBL] [Abstract][Full Text] [Related]
4. Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: A single-institution study.
Umezawa R; Murakami N; Nakamura S; Wakita A; Okamoto H; Tsuchida K; Kashihara T; Kobayashi K; Harada K; Takahashi K; Inaba K; Ito Y; Igaki H; Masui K; Yoshida K; Jingu K; Tselis N; Itami J
Brachytherapy; 2018; 17(2):368-376. PubMed ID: 29275869
[TBL] [Abstract][Full Text] [Related]
5. High-dose-rate interstitial brachytherapy for vaginal endometrial cancer recurrence after prior surgery and radiotherapy.
Chapman CH; Cunha AJ; Littell RD; Chen LM; Hsu IC
Brachytherapy; 2021; 20(3):536-542. PubMed ID: 33549517
[TBL] [Abstract][Full Text] [Related]
6. Re-irradiation with interstitial brachytherapy in uterine cancer patients with vaginal recurrence after post-operative pelvic irradiation.
Murofushi KN; Tanaka R; Ohkawa A; Numajiri H; Minakami S; Okumura T; Sakurai H
J Contemp Brachytherapy; 2022 Feb; 14(1):60-65. PubMed ID: 35233236
[TBL] [Abstract][Full Text] [Related]
7. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
8. Dose rate in the highest irradiation area of the rectum correlates with late rectal complications in patients treated with high-dose-rate computed tomography-based image-guided brachytherapy for cervical cancer.
Isohashi F; Akino Y; Matsumoto Y; Suzuki O; Seo Y; Tamari K; Sumida I; Sawada K; Ueda Y; Kobayashi E; Tomimatsu T; Nakanishi E; Nishi T; Kimura T; Ogawa K
J Radiat Res; 2021 May; 62(3):494-501. PubMed ID: 33866361
[TBL] [Abstract][Full Text] [Related]
9. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
[TBL] [Abstract][Full Text] [Related]
10. High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes.
le Guyader M; Lam Cham Kee D; Thamphya B; Schiappa R; Gautier M; Chand-Fouche ME; Hannoun-Levi JM
Clin Transl Radiat Oncol; 2022 Jan; 32():15-23. PubMed ID: 34816022
[TBL] [Abstract][Full Text] [Related]
11. Reirradiation of locally recurrent nasopharyngeal carcinoma.
Lengyel E; Baricza K; Somogyi A; Olajos J; Pápai Z; Godény M; Németh G; Esik O
Strahlenther Onkol; 2003 May; 179(5):298-305. PubMed ID: 12740656
[TBL] [Abstract][Full Text] [Related]
12. Vaginal tolerance of CT based image-guided high-dose rate interstitial brachytherapy for gynecological malignancies.
Murakami N; Kasamatsu T; Sumi M; Yoshimura R; Harada K; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Ito Y; Itami J
Radiat Oncol; 2014 Jan; 9():31. PubMed ID: 24456669
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible.
Lee TH; Song C; Kim IA; Kim JS; Kim YB; Kim K; No JH; Suh DH; Chung JB; Eom KY
Radiat Oncol; 2021 Aug; 16(1):148. PubMed ID: 34384450
[TBL] [Abstract][Full Text] [Related]
14. CT-based interstitial brachytherapy in advanced gynecologic malignancies: outcomes from a single institution experience.
D'Souza D; Wiebe E; Patil N; Sugimoto A; Prefontaine M; Aulakh S; Whiston F; Stitt L; Surry K
Brachytherapy; 2014; 13(3):225-32. PubMed ID: 24613570
[TBL] [Abstract][Full Text] [Related]
15. Reirradiation using high-dose-rate interstitial brachytherapy for locally recurrent cervical cancer: a single institutional experience.
Mabuchi S; Takahashi R; Isohashi F; Yokoi T; Okazawa M; Sasano T; Maruoka S; Anzai M; Yoshioka Y; Ogawa K; Kimura T
Int J Gynecol Cancer; 2014 Jan; 24(1):141-8. PubMed ID: 24362719
[TBL] [Abstract][Full Text] [Related]
16. Toward four-dimensional image-guided adaptive brachytherapy in locally recurrent endometrial cancer.
Fokdal L; Ørtoft G; Hansen ES; Røhl L; Pedersen EM; Tanderup K; Lindegaard JC
Brachytherapy; 2014; 13(6):554-61. PubMed ID: 25056640
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors and outcome of reirradiation for locally recurrent small cell lung cancer-a multicenter study.
Käsmann L; Janssen S; Baschnagel AM; Kruser TJ; Harada H; Aktan M; Rades D
Transl Lung Cancer Res; 2020 Apr; 9(2):232-238. PubMed ID: 32420062
[TBL] [Abstract][Full Text] [Related]
18. Single Application Multifractionated Image Guided Adaptive High-Dose-Rate Brachytherapy for Cervical Cancer: Dosimetric and Clinical Outcomes.
Mahantshetty U; Gurram L; Bushra S; Ghadi Y; Aravindakshan D; Paul J; Hande V; Pilar A; Chopra S; Ghosh J; Shylasree TS; Popat P; Sable N; Maheswari A; Gupta S
Int J Radiat Oncol Biol Phys; 2021 Nov; 111(3):826-834. PubMed ID: 34146636
[TBL] [Abstract][Full Text] [Related]
19. Late rectal toxicity after image-based high-dose-rate interstitial brachytherapy for postoperative recurrent and/or residual cervical cancers: EQD2 predictors for Grade ≥II toxicity.
Chopra S; Dora T; Engineer R; Mechanery S; Agarwal P; Kannan S; Ghadi Y; Swamidas J; Mahantshetty U; Shrivastava SK
Brachytherapy; 2015; 14(6):881-8. PubMed ID: 26409708
[TBL] [Abstract][Full Text] [Related]
20. A Prospective Study of High Dose-Rate Brachytherapy or Stereotactic Body Radiotherapy of Intra-Prostatic Recurrence: Toxicity and Long Term Clinical Outcome.
Ryg U; Seierstad T; Nilsen LB; Hellebust TP; Djupvik LH; Gustafson H; Hydal J; Kishan AU; Hole KH; Lilleby W
Front Oncol; 2022; 12():861127. PubMed ID: 35463376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]